Washington JM, ed. Neurologic Disorders in Pregnancy. New York, NY: The Parthenon Publishing Group; 2004.
Kim MJ, Kim J, Hwang EJ, Song Y, Kim H, Hyun T. Awareness, knowledge, and use of folic acid among non-pregnant Korean women of childbearing age. Nutr Res Pract. 2018 Feb. 12 (1):78-84. [Medline]. [Full Text].
Kim J, Yon M, Kim CI, Lee Y, Moon GI, Hong J, et al. Preconceptional use of folic acid and knowledge about folic acid among low-income pregnant women in Korea. Nutr Res Pract. 2017 Jun. 11 (3):240-246. [Medline]. [Full Text].
Friedman JM, Little BB, Brent RL, et al. Potential human teratogenicity of frequently prescribed drugs. Obstet Gynecol. 1990 Apr. 75(4):594-9. [Medline].
Lo WY, Friedman JM. Teratogenicity of recently introduced medications in human pregnancy. Obstet Gynecol. 2002. 100:465-7. [Medline].
Murray L, Seger D. Drug therapy during pregnancy and lactation. Emerg Med Clin North Am. 1994 Feb. 12(1):129-49. [Medline].
Ekawa Y, Shiota M, Tobiume T, Shimaoka M, Tsuritani M, Kotani Y, et al. Reversible posterior leukoencephalopathy syndrome accompanying eclampsia: correct diagnosis using preoperative MRI. Tohoku J Exp Med. 2012. 226(1):55-8. [Medline].
Hinchey J, Chaves C, Appignani B, et al. A reversible posterior leukoencephalopathy syndrome. N Engl J Med. 1996 Feb 22. 334(8):494-500. [Medline].
Fischer M, Schmutzhard E. Posterior reversible encephalopathy syndrome. J Neurol. 2017 Aug. 264 (8):1608-1616. [Medline]. [Full Text].
Xiaobo F, Yanling L, Dunjin C, Fang H, Jia C, Yuhua Z, et al. Effect of blood pressure on reversible posterior leukoencephalopathy syndrome in pre-eclampsia or eclampsia. Hypertens Res. 2018 Feb. 41 (2):112-117. [Medline].
University of Western Ontario neurology residents. Reversible posterior leukoencephalopathy syndrome (RPLE). Neurological Medicine Pocketbook. August 2004. [Full Text].
Swartz RH, Cayley ML, Foley N, Ladhani NNN, Leffert L, Bushnell C, et al. The incidence of pregnancy-related stroke: A systematic review and meta-analysis. Int J Stroke. 2017 Oct. 12 (7):687-697. [Medline].
Hopkins AN, Alshaeri T, Akst SA, Berger JS. Neurologic disease with pregnancy and considerations for the obstetric anesthesiologist. Semin Perinatol. 2014 Oct. 38(6):359-69. [Medline].
Negro A, Delaruelle Z, Ivanova TA, Khan S, Ornello R, Raffaelli B, et al. Headache and pregnancy: a systematic review. J Headache Pain. 2017 Oct 19. 18 (1):106. [Medline]. [Full Text].
Wainscott G, Sullivan FM, Volans GN, Wilkinson M. The outcome of pregnancy in women suffering from migraine. Postgrad Med J. 1978 Feb. 54(628):98-102. [Medline]. [Full Text].
Facchinetti F, Allais G, Nappi RE, et al. Migraine is a risk factor for hypertensive disorders in pregnancy: a prospective cohort study. Cephalalgia. 2009 Mar. 29(3):286-92. [Medline].
The Sumatriptan/Naratriptan/Treximet Pregnancy Registry: Interim Report 1 January 1996 through 30 April 2011. Available at http://pregnancyregistry.gsk.com/documents/SumNarTrex_InterimReport_2011.pdf. Accessed: February 9, 2012.
Harden CL, Hopp J, Ting TY, et al. Practice parameter update: management issues for women with epilepsy--focus on pregnancy (an evidence-based review): obstetrical complications and change in seizure frequency: report of the Quality Standards Subcommittee and Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology and American Epilepsy Society. Neurology. 2009 Jul 14. 73(2):126-32. [Medline].
[Guideline] Harden CL, Meador KJ, Pennell PB, et al. Practice parameter update: management issues for women with epilepsy--focus on pregnancy (an evidence-based review): teratogenesis and perinatal outcomes: report of the Quality Standards Subcommittee and Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology and American Epilepsy Society. Neurology. 2009 Jul 14. 73(2):133-41. [Medline].
[Guideline] Harden CL, Pennell PB, Koppel BS, et al. Practice parameter update: management issues for women with epilepsy--focus on pregnancy (an evidence-based review): vitamin K, folic acid, blood levels, and breastfeeding: report of the Quality Standards Subcommittee and Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology and American Epilepsy Society. Neurology. 2009 Jul 14. 73(2):142-9. [Medline].
Pittschieler S, Brezinka C, Jahn B, et al. Spontaneous abortion and the prophylactic effect of folic acid supplementation in epileptic women undergoing antiepileptic therapy. J Neurol. 2008. 255:1926-31. [Medline].
Lindhout D, Meinardi H, Meijer JW, Nau H. Antiepileptic drugs and teratogenesis in two consecutive cohorts: changes in prescription policy paralleled by changes in pattern of malformations. Neurology. 1992 Apr. 42(4 Suppl 5):94-110. [Medline].
Meador KJ, Baker GA, Browning N, Clayton-Smith J, Combs-Cantrell DT, Cohen M, et al. Cognitive function at 3 years of age after fetal exposure to antiepileptic drugs. N Engl J Med. 2009 Apr 16. 360(16):1597-605. [Medline]. [Full Text].
Baker GA, Bromley RL, Briggs M, Cheyne CP, Cohen MJ, García-Fiñana M, et al. IQ at 6 years after in utero exposure to antiepileptic drugs: A controlled cohort study. Neurology. 2015 Jan 27. 84(4):382-90. [Medline].
Jentink J, Dolk H, Loane MA, Morris JK, Wellesley D, Garne E, et al. Intrauterine exposure to carbamazepine and specific congenital malformations: systematic review and case-control study. BMJ. 2010 Dec 2. 341:c6581. [Medline]. [Full Text].
Holmes LB, Wyszynski DF, Baldwin EJ, et al. Increased risk for non-syndromic cleft palate among infants exposed to lamotrigine during pregnancy [abstract]. Birth Defects Res A Clin Mol Teratol. 2006. 76(5):318.
Holmes LB, Wyszynski DF, Lieberman E. The AED (antiepileptic drug) pregnancy registry: a 6-year experience. Arch Neurol. 2004 May. 61(5):673-8. [Medline].
Meador KJ, Baker GA, Finnell RH, et al. In utero antiepileptic drug exposure: fetal death and malformations. Neurology. 2006 Aug 8. 67(3):407-12. [Medline].
Birnbaum CS, Cohen LS, Bailey JW, et al. Serum concentrations of antidepressants and benzodiazepines in nursing infants: A case series. Pediatrics. 1999 Jul. 104(1):e11. [Medline].
Iqbal MM, Sobhan T, Ryals T. Effects of commonly used benzodiazepines on the fetus, the neonate, and the nursing infant. Psychiatr Serv. 2002 Jan. 53(1):39-49. [Medline].
Meador KJ, Baker GA, Browning N, Clayton-Smith J, Combs-Cantrell DT, Cohen M, et al. Effects of breastfeeding in children of women taking antiepileptic drugs. Neurology. 2010 Nov 30. 75(22):1954-60. [Medline].
Santiago JR, Nolledo MS, Kinzler W, Santiago TV. Sleep and sleep disorders in pregnancy. Ann Intern Med. 2001 Mar 6. 134(5):396-408. [Medline].
Manconi M, Govoni V, De Vito A, et al. Restless legs syndrome and pregnancy. Neurology. 2004 Sep 28. 63(6):1065-9. [Medline].
Sahota PK, Jain SS, Dhand R. Sleep disorders in pregnancy. Curr Opin Pulm Med. 2003 Nov. 9(6):477-83. [Medline].
Yinon D, Lowenstein L, Suraya S, et al. Pre-eclampsia is associated with sleep-disordered breathing and endothelial dysfunction. Eur Respir J. 2006 Feb. 27(2):328-33. [Medline].
DOUGLASS LH, JORGENSEN CL. Pregnancy and multiple sclerosis. Am J Obstet Gynecol. 1948 Feb. 55(2):332-6. [Medline].
Bennett KA. Pregnancy and multiple sclerosis. Clin Obstet Gynecol. 2005 Mar. 48(1):38-47. [Medline].
Coyle PK. Multiple sclerosis and pregnancy prescriptions. Expert Opin Drug Saf. 2014 Dec. 13(12):1565-8. [Medline].
Dahl J, Myhr KM, Daltveit AK, et al. Pregnancy, delivery, and birth outcome in women with multiple sclerosis. Neurology. 2005 Dec 27. 65(12):1961-3. [Medline].
Worthington J, Jones R, Crawford M, Forti A. Pregnancy and multiple sclerosis--a 3-year prospective study. J Neurol. 1994 Feb. 241(4):228-33. [Medline].
Korn-Lubetzki I, Kahana E, Cooper G, Abramsky O. Activity of multiple sclerosis during pregnancy and puerperium. Ann Neurol. 1984 Aug. 16(2):229-31. [Medline].
Salemi G, Callari G, Gammino M, et al. The relapse rate of multiple sclerosis changes during pregnancy: a cohort study. Acta Neurol Scand. 2004 Jul. 110(1):23-6. [Medline].
Confavreux C, Hutchinson M, Hours MM, et al. Rate of pregnancy-related relapse in multiple sclerosis. Pregnancy in Multiple Sclerosis Group. N Engl J Med. 1998 Jul 30. 339(5):285-91. [Medline].
Roullet E, Verdier-Taillefer MH, Amarenco P, et al. Pregnancy and multiple sclerosis: a longitudinal study of 125 remittent patients. J Neurol Neurosurg Psychiatry. 1993 Oct. 56(10):1062-5. [Medline].
Bebo BF, Dveksler GS. Evidence that pregnancy specific glycoproteins regulate T-Cell function and inflammatory autoimmune disease during pregnancy. Curr Drug Targets Inflamm Allergy. 2005 Apr. 4(2):231-7. [Medline].
Millar JH, Allison RS, Cheeseman EA, Merrett JD. Pregnancy as a factor influencing relapse in disseminated sclerosis. Brain. 1959 Sep. 82:417-26. [Medline].
Vukusic S, Hutchinson M, Hours M, et al. Pregnancy and multiple sclerosis (the PRIMS study): clinical predictors of post-partum relapse. Brain. 2004 Jun. 127(Pt 6):1353-60. [Medline].
Nelson LM, Franklin GM, Jones MC, et al. Risk of multiple sclerosis exacerbation during pregnancy and breast-feeding. JAMA. 1988 Jun 17. 259(23):3441-3. [Medline].
Gulick EE, Johnson S. Infant health of mothers with multiple sclerosis. West J Nurs Res. 2004 Oct. 26(6):632-49. [Medline].
Miller DH, Molyneux PD, Barker GJ, et al. Effect of interferon-beta1b on magnetic resonance imaging outcomes in secondary progressive multiple sclerosis: results of a European multicenter, randomized, double-blind, placebo-controlled trial. European Study Group on Interferon-beta1b in secondary. Ann Neurol. 1999 Dec. 46(6):850-9. [Medline].
Boskovic R, Wide R, Wolpin J, et al. The reproductive effects of beta interferon therapy in pregnancy: a longitudinal cohort. Neurology. 2005 Sep 27. 65(6):807-11. [Medline].
Sandberg-Wollheim M, Frank D, Goodwin TM, et al. Pregnancy outcomes during treatment with interferon beta-1a in patients with multiple sclerosis. Neurology. 2005 Sep 27. 65(6):802-6. [Medline].
Lisak RP. Overview of the rationale for immunomodulating therapies in multiple sclerosis. Neurology. 1988 Jul. 38(7 Suppl 2):5-8. [Medline].
Orvieto R, Achiron R, Rotstein Z, et al. Pregnancy and multiple sclerosis: a 2-year experience. Eur J Obstet Gynecol Reprod Biol. 1999 Feb. 82(2):191-4. [Medline].
British and Dutch Multiple Sclerosis Azathioprine Trial Group. Double-masked trial of azathioprine in multiple sclerosis. Lancet. 1988 Jul 23. 2(8604):179-83. [Medline].
Yudkin PL, Ellison GW, Ghezzi A, et al. Overview of azathioprine treatment in multiple sclerosis. Lancet. 1991 Oct 26. 338(8774):1051-5. [Medline].
Ferrero S, Pretta S, Ragni N. Multiple sclerosis: management issues during pregnancy. Eur J Obstet Gynecol Reprod Biol. 2004 Jul 15. 115(1):3-9. [Medline].
de Seze J, Chapelotte M, Delalande S, et al. Intravenous corticosteroids in the postpartum period for reduction of acute exacerbations in multiple sclerosis. Mult Scler. 2004 Oct. 10(5):596-7. [Medline].
Achiron A, Rotstein Z, Noy S, et al. Intravenous immunoglobulin treatment in the prevention of childbirth-associated acute exacerbations in multiple sclerosis: a pilot study. J Neurol. 1996 Jan. 243(1):25-8. [Medline].
Achiron A, Kishner I, Dolev M, et al. Effect of intravenous immunoglobulin treatment on pregnancy and postpartum-related relapses in multiple sclerosis. J Neurol. 2004 Sep. 251(9):1133-7. [Medline].
Haas J. High dose IVIG in the post partum period for prevention of exacerbations in MS. Mult Scler. 2000 Oct. 6 Suppl 2:S18-20; discussion S33. [Medline].
Hoff JM, Daltveit AK, Gilhus NE. Myasthenia gravis: consequences for pregnancy, delivery, and the newborn. Neurology. 2003 Nov 25. 61(10):1362-6. [Medline].
Rahman R, Hoq MS, Arifuzzaman M, Kabir MA, Khanam NN. Pregnancy with myasthenia gravis. Mymensingh Med J. 2014 Apr. 23(2):395-400. [Medline].
Djelmis J, Sostarko M, Mayer D, Ivanisevic M. Myasthenia gravis in pregnancy: report on 69 cases. Eur J Obstet Gynecol Reprod Biol. 2002 Aug 5. 104(1):21-5. [Medline].
Batocchi AP, Majolini L, Evoli A, et al. Course and treatment of myasthenia gravis during pregnancy. Neurology. 1999 Feb. 52(3):447-52. [Medline].
Ciafaloni E, Massey JM. The management of myasthenia gravis in pregnancy. Semin Neurol. 2004 Mar. 24(1):95-100. [Medline].
Jackson CE. Patient page. The effect of myasthenia gravis on pregnancy and the newborn. Neurology. 2003 Nov 25. 61(10):1459-60. [Medline].
Shehata HA, Okosun H. Neurological disorders in pregnancy. Curr Opin Obstet Gynecol. 2004 Apr. 16(2):117-22. [Medline].
Plauche WC. Myasthenia gravis in mothers and their newborns. Clin Obstet Gynecol. 1991 Mar. 34(1):82-99. [Medline].
Riemersma S, Vincent A, Beeson D, et al. Association of arthrogryposis multiplex congenita with maternal antibodies inhibiting fetal acetylcholine receptor function. J Clin Invest. 1996 Nov 15. 98(10):2358-63. [Medline].
Gardnerova M, Eymard B, Morel E, et al. The fetal/adult acetylcholine receptor antibody ratio in mothers with myasthenia gravis as a marker for transfer of the disease to the newborn. Neurology. 1997 Jan. 48(1):50-4. [Medline].
Waddy S, Stern BJ. Cerebrovascular disease in pregnancy. In: Washington JM, ed. Neurologic Disorders in Pregnancy. New York, NY: Parthenon; 2004. 39-51.
Coppage KH, Hinton AC, Moldenhauer J, et al. Maternal and perinatal outcome in women with a history of stroke. Am J Obstet Gynecol. 2004 May. 190(5):1331-4. [Medline].
Jeng JS, Tang SC, Yip PK. Stroke in women of reproductive age: comparison between stroke related and unrelated to pregnancy. J Neurol Sci. 2004 Jun 15. 221(1-2):25-9. [Medline].
Johnson CJ, Jangula JC. Cerebrovascular disease in women. In: Kaplan PW, ed. Neurologic Disease in Women. New York, NY: Demos Medical Publishing; 2004. 219-27.
Bushnell C, Chireau M. Preeclampsia and Stroke: Risks during and after Pregnancy. Stroke Res Treat. 2011 Jan 20. 2011:858134. [Medline]. [Full Text].
Del Zotto E, Giossi A, Volonghi I, Costa P, Padovani A, Pezzini A. Ischemic Stroke during Pregnancy and Puerperium. Stroke Res Treat. 2011 Jan 27. 2011:606780. [Medline]. [Full Text].
Yamaguchi Y, Kondo T, Ihara M, Kawamata J, Fukuyama H, Takahashi R. [Intravenous recombinant tissue plasminogen activator in an 18-week pregnant woman with embolic stroke]. Rinsho Shinkeigaku. 2010 May. 50(5):315-9. [Medline].
Tassi R, Acampa M, Marotta G, Cioni S, Guideri F, Rossi S, et al. Systemic thrombolysis for stroke in pregnancy. Am J Emerg Med. 2013 Feb. 31(2):448.e1-3. [Medline].
Demchuk AM. Yes, intravenous thrombolysis should be administered in pregnancy when other clinical and imaging factors are favorable. Stroke. 2013 Mar. 44(3):864-5. [Medline].
Broderick JP. Should intravenous thrombolysis be considered the first option in pregnant women?. Stroke. 2013 Mar. 44(3):866-7. [Medline].
Selim MH, Molina CA. The use of tissue plasminogen-activator in pregnancy: a taboo treatment or a time to think out of the box. Stroke. 2013 Mar. 44(3):868-9. [Medline].
Kochi MH, Kaloudis EV, Ahmed W, Moore WH. Effect of in utero exposure of iodinated intravenous contrast on neonatal thyroid function. J Comput Assist Tomogr. 2012 Mar-Apr. 36(2):165-9. [Medline].
Atwell TD, Lteif AN, Brown DL, McCann M, Townsend JE, Leroy AJ. Neonatal thyroid function after administration of IV iodinated contrast agent to 21 pregnant patients. AJR Am J Roentgenol. 2008 Jul. 191(1):268-71. [Medline].
[Guideline] Fergus Coakley, Robert Gould, Russell K Laros Jr, Mari-Paule Thiet. Guidelines for the Use of CT and MRI During Pregnancy and Lactation. University of Southern California San Francisco. Available at http://radiology.ucsf.edu/patient-care/patient-safety/ct-mri-pregnancy. Accessed: January 7, 2015.